Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism

Anxa2 is the most studied member of the calcium-mediated phospholipid-binding protein family annexins and is a biomarker in cancers. In this review, we listed clinical findings and confirmed the value of Anxa2 in early diagnosis and prognostic prediction due to its overexpression and adverse effect...

Full description

Bibliographic Details
Main Authors: Tong Wang, Zhiyong Wang, Ruifang Niu, Liang Wang
Format: Article
Language:English
Published: China Anti-Cancer Association 2019-12-01
Series:Cancer Biology & Medicine
Subjects:
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1514
_version_ 1818017512626847744
author Tong Wang
Zhiyong Wang
Ruifang Niu
Liang Wang
author_facet Tong Wang
Zhiyong Wang
Ruifang Niu
Liang Wang
author_sort Tong Wang
collection DOAJ
description Anxa2 is the most studied member of the calcium-mediated phospholipid-binding protein family annexins and is a biomarker in cancers. In this review, we listed clinical findings and confirmed the value of Anxa2 in early diagnosis and prognostic prediction due to its overexpression and adverse effect on the outcome in most tumors. Anxa2 plays a pivotal role in cancer cell proliferation, migration, invasion, metastasis, and treatment resistance. Improved understanding of its cancer-promoting function might make it an ideal target for cancer therapy. Here, we systematically summarized the mechanism of Anxa2 in regulating epithelial-mesenchymal transition (EMT), cytoskeleton dynamicity, cell cycle, apoptosis, angiogenesis, and immunology by using various tumor models. These data emphasize the potential of Anxa2 for targeted intervention in tumors. Altering Anxa2 expression, neutralizing the cell surface Anxa2, or inhibiting its activation, such as through Tyr23 phosphorylation, could be considered based on the regulatory mechanism of Anxa2 in tumor progression.
first_indexed 2024-04-14T07:29:03Z
format Article
id doaj.art-35e00562561344d4b9b16d8c8ad86e0d
institution Directory Open Access Journal
issn 2095-3941
2095-3941
language English
last_indexed 2024-04-14T07:29:03Z
publishDate 2019-12-01
publisher China Anti-Cancer Association
record_format Article
series Cancer Biology & Medicine
spelling doaj.art-35e00562561344d4b9b16d8c8ad86e0d2022-12-22T02:05:56ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412095-39412019-12-0116467168710.20892/j.issn.2095-3941.2019.0228CBM-2019-0228Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanismTong Wang0Zhiyong Wang1Ruifang Niu2Liang Wang3Second Department of Breast TumorPublic Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, ChinaPublic Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, ChinaModern Distance Education College, Nankai University, Tianjin 300071, ChinaAnxa2 is the most studied member of the calcium-mediated phospholipid-binding protein family annexins and is a biomarker in cancers. In this review, we listed clinical findings and confirmed the value of Anxa2 in early diagnosis and prognostic prediction due to its overexpression and adverse effect on the outcome in most tumors. Anxa2 plays a pivotal role in cancer cell proliferation, migration, invasion, metastasis, and treatment resistance. Improved understanding of its cancer-promoting function might make it an ideal target for cancer therapy. Here, we systematically summarized the mechanism of Anxa2 in regulating epithelial-mesenchymal transition (EMT), cytoskeleton dynamicity, cell cycle, apoptosis, angiogenesis, and immunology by using various tumor models. These data emphasize the potential of Anxa2 for targeted intervention in tumors. Altering Anxa2 expression, neutralizing the cell surface Anxa2, or inhibiting its activation, such as through Tyr23 phosphorylation, could be considered based on the regulatory mechanism of Anxa2 in tumor progression.http://www.cancerbiomed.org/index.php/cocr/article/view/1514anxa2cancerdiagnosisprognosismetastasistreatment resistance
spellingShingle Tong Wang
Zhiyong Wang
Ruifang Niu
Liang Wang
Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
Cancer Biology & Medicine
anxa2
cancer
diagnosis
prognosis
metastasis
treatment resistance
title Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
title_full Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
title_fullStr Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
title_full_unstemmed Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
title_short Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
title_sort crucial role of anxa2 in cancer progression highlights on its novel regulatory mechanism
topic anxa2
cancer
diagnosis
prognosis
metastasis
treatment resistance
url http://www.cancerbiomed.org/index.php/cocr/article/view/1514
work_keys_str_mv AT tongwang crucialroleofanxa2incancerprogressionhighlightsonitsnovelregulatorymechanism
AT zhiyongwang crucialroleofanxa2incancerprogressionhighlightsonitsnovelregulatorymechanism
AT ruifangniu crucialroleofanxa2incancerprogressionhighlightsonitsnovelregulatorymechanism
AT liangwang crucialroleofanxa2incancerprogressionhighlightsonitsnovelregulatorymechanism